Eli Lilly will buy Orna Therapeutics for up to $2.4 billion in cash, gaining access to a technology that allows patients’ own cells to generate therapies inside the body, without the need to extract them.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets